Parminder K Judge

4PUBLICATIONS
28CO-AUTHORS
Foetal development and medicineMajor global burdens of diseasePharmacogenomicsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Apr 10, 2026
Hierarchical Composite End Points: The Future of Randomized Trials of Kidney Disease?

Natalie Staplin, Parminder K Judge

|Apr 03, 2025
Frailty, Multimorbidity, and Polypharmacy: Exploratory Analyses of the Effects of Empagliflozin from the EMPA-KIDNEY Trial.

Kaitlin J Mayne, Rebecca J Sardell, Natalie Staplin

|Jul 01, 2024
Frailty, multimorbidity and polypharmacy: exploratory analyses of the effects of empagliflozin from the EMPA-KIDNEY trial.

Kaitlin J Mayne, Rebecca J Sardell, Natalie Staplin

|Dec 12, 2023
Effects of Empagliflozin on Fluid Overload, Weight, and Blood Pressure in CKD.

Kaitlin J Mayne, Natalie Staplin, David F Keane

Pageof 1